Physician profile
Steven E Georgeson
NPI 1487627741
$3,646.56
in general payments reported to CMS, 2019-2025
32 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $449 · 2021: $463 · 2022: $425 · 2023: $786 · 2024: $393 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $491.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $402.84 | 2019-2025 | |
| Amgen INC. | $396.88 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $395.55 | 2022-2024 | Watchman Access System, Watchman Flx, Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.97 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $228.04 | 2019-2025 | Camzyos |
| Edwards Lifesciences Corporation | $159.19 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $158.90 | 2023-2025 | Impella |
| Janssen Pharmaceuticals, INC | $142.02 | 2019-2024 | Xarelto |
| Abbott Laboratories | $122.27 | 2019-2025 | Aveir, Amplatzer Amulet |
| Merck Sharp & Dohme LLC | $113.33 | 2021-2025 | Verquvo |
| Esperion Therapeutics, INC. | $111.92 | 2021-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.90 | 2023-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $85.51 | 2023-2025 | Onpattro |
| Amarin Pharma, INC. | $82.81 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $61.82 | 2020-2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $47.74 | 2019-2023 | |
| Cvrx, INC. | $46.52 | 2025 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $40.14 | 2020-2021 | |
| Scpharmaceuticals INC. | $36.98 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $30.57 | 2024 | Venclose Maven Catheter |
| Arbor Pharmaceuticals, INC. | $27.82 | 2019-2021 | |
| Atricure, INC. | $21.46 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.73 | 2025 | |
| Biosense Webster, INC. | $17.64 | 2025 | Carto 3 |
| Medtronic, INC. | $17.26 | 2021 | |
| Daiichi Sankyo INC. | $14.99 | 2022 | |
| Lundbeck LLC | $14.97 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.40 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $14.29 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $13.42 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Georgeson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.